Health Sciences
Hope for patients with a severe rare disease
Research
ETH Zurich
New research offers potential benefits for those affected by the hereditary metabolic disease methylmalonic aciduria. By combining the results of multiple molecular analyses, scientists can better diagnose this rare and severe disease. In the future, an improved understanding of the disease might also improve treatment options.
More Precise Treatment
Research
ETH Zurich
The LOOP Zurich research center combines expertise from ETH Zurich, the University of Zurich and the four university hospitals in Zurich with the aim of developing more personalized therapies. Two new projects supported by The LOOP Zurich target urinary tract infections and obesity respectively.
Diagnosing diseases with a puff of breath
Research
ETH Zurich
A needle and some blood are usually needed for medical diagnostics.
A pioneer in detailed diagnostics
Research
ETH Zurich
Gregor Weiss used state-of-the-art microscopy to show how the body prevents bladder infections. He now wants to make this method from basic research usable for the analysis of patient samples – and has received the Lopez-Loreta Prize for it.
A chip to replace animal testing
Research
Empa ETH Zurich
Empa researchers are developing a medical chip in collaboration with the ETH Zurich and the Cantonal Hospital of St. Gallen that will allow statements to be made about the effect of substances on babies in the womb. The Zurich-based ProCare Foundation is funding the project, which was recently launched.
Monitoring antibiotic resistance in wastewater
Research
Eawag
Researchers at Eawag recommend setting up a monitoring system for antibiotic resistance in the synthesis report of the National Research Programme NRP 72 Antimicrobial resistance, similar to the wastewater monitoring for Sars-CoV-2.
Page 11 of 23